Mind Medicine (MindMed), Inc. (MNMD)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Mind Medicine (MindMed), Inc. (MNMD)
Go deeper and ask any question about MNMD
Company Performance
Current Price
as of Sep 13, 2024$6.45
P/E Ratio
N/A
Market Cap
$524.78M
Description
Mind Medicine (MindMed), Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.
Metrics
Overview
- HQNew York, NY
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerMNMD
- Price$6.45+4.37%
Trading Information
- Market Cap$524.78M
- Float96.81%
- Average Daily Volume (1m)883,006
- Average Daily Volume (3m)1,182,726
- EPS-$2.26
Company
- RevenueN/A
- Rev Growth (1yr)N/A
- Net Income-$5.85M
- Gross MarginN/A
- EBITDA MarginN/A
- EBITDA-$24.46M
- EV$299.61M
- EV/RevenueN/A
- P/EN/A
- P/SN/A
Documents
SEC Filings
Factset Street Account